Acadia Healthcare Company, Inc.
ACHC
$29.91
$0.230.78%
| Weiss Ratings | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.85 | |||
| Price History | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -29.37% | |||
| 30-Day Total Return | -32.42% | |||
| 60-Day Total Return | -27.93% | |||
| 90-Day Total Return | -41.08% | |||
| Year to Date Total Return | -26.64% | |||
| 1-Year Total Return | -64.70% | |||
| 2-Year Total Return | -59.22% | |||
| 3-Year Total Return | -51.39% | |||
| 5-Year Total Return | 1.46% | |||
| 52-Week High % Change | -65.47% | |||
| 52-Week Low % Change | 5.66% | |||
| Price | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $85.96 | |||
| 52-Week Low Price | $28.09 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.76B | |||
| Enterprise Value | 4.89B | |||
| Price/Earnings (TTM) | 10.69 | |||
| Earnings Per Share (TTM) | 2.78 | |||
| Earnings Per Share Growth | -1,179.08% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.87 | |||
| Price/Book (Q) | 0.89 | |||
| Enterprise Value/Revenue (TTM) | 1.55 | |||
| Price | $29.91 | |||
| Enterprise Value/EBITDA (TTM) | 7.28 | |||
| Enterprise Value/EBIT | 9.37 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 91.99M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 615 861 6000 | |||
| Address | 6100 Tower Circle Franklin, TN 37067 | |||
| Website | www.acadiahealthcare.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 16.55% | |||
| Profit Margin | 8.10% | |||
| Management Effectiveness | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.77% | |||
| Return on Equity | 8.70% | |||
| Income Statement | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.15B | |||
| Total Revenue (TTM) | 3.15B | |||
| Revenue Per Share | $34.29 | |||
| Gross Profit (TTM) | 1.35B | |||
| EBITDA (TTM) | 671.87M | |||
| EBIT (TTM) | 522.28M | |||
| Net Income (TTM) | 255.61M | |||
| Net Income Avl. to Common (TTM) | 255.61M | |||
| Total Revenue Growth (Q YOY) | 4.23% | |||
| Earnings Growth (Q YOY) | -43.89% | |||
| EPS Diluted (TTM) | 2.78 | |||
| EPS Diluted Growth (Q YOY) | -42.94% | |||
| Balance Sheet | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 76.31M | |||
| Cash Per Share (Q) | $0.83 | |||
| Total Current Assets (Q) | 577.49M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.19B | |||
| Current Ratio (Q) | 0.999 | |||
| Book Value Per Share (Q) | $33.49 | |||
| Total Assets (Q) | 5.96B | |||
| Total Current Liabilities (Q) | 577.92M | |||
| Total Debt (Q) | 2.10B | |||
| Total Liabilities (Q) | 2.77B | |||
| Total Common Equity (Q) | 3.07B | |||
| Cash Flow | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -736.48M | |||
| Cash from Financing (TTM) | 583.02M | |||
| Net Change in Cash (TTM) | -23.77M | |||
| Levered Free Cash Flow (TTM) | -605.91M | |||
| Cash from Operations (TTM) | 129.69M | |||
